Life Science Compliance Update

May

2017

Changing the Rules Again: The MedTech Europe Code & Third-Party Educational Support

Written by , Posted in Global Issues

Jenny McVey, Life Sciences Manager, Mark Scallon, Life Sciences Partner, FRA

Although the new code of conduct for member medical device and in-vitro diagnostic companies operating in the European marketplace has come into force the first day of this year, a grace period has been granted before new principles become effective. This article reviews the changes medical device and in-vitro diagnostic companies should consider implementing.

Menu Title